Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CARRASYN FDG

K-Number: K944427 · 1994-11-29

ApplicantCarrington Laboratories, Inc.
Decision Date1994-11-29
Product CodeMGQ
DecisionSubstantially Equivalent for Some Indications

Device Summary

CARRASYN FDG is the device name listed in this FDA 510(k) record. The listed applicant is Carrington Laboratories, Inc.. It received FDA 510(k) clearance on 1994-11-29 under 510(k) number K944427. The device is classified under product code MGQ. FDA Decision: Substantially Equivalent for Some Indications.

Frequently Asked Questions

What is the CARRASYN FDG?

CARRASYN FDG is a medical device that received FDA 510(k) clearance on 1994-11-29. The listed applicant is Carrington Laboratories, Inc.. The 510(k) number is K944427.

When did CARRASYN FDG receive FDA 510(k) clearance?

CARRASYN FDG received FDA 510(k) clearance on 1994-11-29, under 510(k) number K944427.

Who is the listed applicant for CARRASYN FDG?

The FDA 510(k) record lists Carrington Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CARRASYN FDG?

The FDA product code for CARRASYN FDG is MGQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Carrington Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K022670CARRAKLENZ AND ULTRAKLENZK012126THE SALICEPT ORAL PATCHK983182ALOE THERAPY ORAL RINSEK964852RADIACARE ORAL WOUND RINSEK962218CARRASYN HYDROGEL WOUND DRESSING,CARRAGAUZE PADS,CARRAGAUZE STRIPS,CARRASORB M FDGK961758CARASYN HYDROGEL WOUND PRODUCTS

View all 15 devices →

Related Devices (Code: MGQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K171879HylaGuard Moisturizing CreamFounders Science Group, LLCK083024HYLATOPIC EMOLLIENT FOAMCollegium Pharmaceutical IncorporatedK041342IMPRUV A.I. CREAM WOUND AND SKIN EMULSIONStiefel Laboratories, Inc.K041268SILVERSITE OR CALGITROLAdriK040019SILVERSEALNoble Fiber TechnologiesK040517TENDERWET ACTIVEMedline Industries, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑